Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 38,777,166	$ 1,174,608
Prepaid expenses and other current assets	343,091	1,499,219
Short-term notes receivable, net of allowance for credit losses of $261,000 at September 30, 2025 and $360,000 at December 31, 2024	4,348,107	2,010,692
Total current assets	43,468,364	4,684,519
Other assets	2,000	2,000
Total Assets	43,470,364	4,686,519
Current liabilities
Accounts payable	1,282,224	1,568,065
Accrued expenses and other current liabilities	41,896	170,243
Warrant liabilities	362,323	269,175
Convertible debt	339,736
Promissory notes	2,897,107
Total current liabilities	4,923,286	2,007,483
Commitments and Contingencies (Note 10)
Stockholders’ Equity (Deficit)
Preferred stock, $0.001 par value; 15,000,000 shares authorized; 45,044 and 6,256 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	36,100,334	5,716,400
Common stock, $0.001 par value; 225,000,000 shares authorized; 3,056,822 and 736,431 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	67,734	65,314
Additional paid-in capital	131,809,991	119,958,897
Accumulated deficit	(129,430,981)	(123,061,575)
Total Stockholders’ Equity (Deficit)	38,547,078	2,679,036
Total Liabilities & Stockholders’ Equity (Deficit)	$ 43,470,364	$ 4,686,519

Warrant liabilities current.

No definition available.

Name:	QLGN_WarrantLiabilitiesCurrent
Namespace Prefix:	QLGN_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).